Clinical Trial Update: THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether N-acetylcysteine can attenuate cisplatin-induced toxicities via reducing oxidative stress in patients with head and neck cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Head and Neck Neoplasms | Phase 4 | Status: UNKNOWN